("RenovoRx" or the "Company") (Nasdaq: RNXT), is a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform.
Recently, the Company announced the...
NurExone (TSXV: NRX) (Germany: J90) (the “Company” or “NurExone") is a pioneering biopharmaceutical company developing regenerative medicine therapies.
For a quick catch up on NRX, here are...
Nurexone Biologic Inc. leads the charge in developing cutting-edge exosome-based therapies for central nervous system injuries, particularly traumatic spinal cord injuries (tSCI), promising groundbreaking...
Vistagen (Nasdaq: VTGN) is a San Francisco-based biopharmaceutical company pioneering neuroscience. Its treatments deliver ground-breaking therapies for individuals affected by psychiatric and neurological disorders. Recently,...
● Leading the charge in exosome-based medicine, NurExone pioneers ExoTherapy, utilizing tiny cell-secreted particles to deliver treatments like ExoPTEN, focusing on spinal cord injury recovery — a...